Seroba Life Sciences Management
Finance · Ireland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Herbert St, Dublin, South Dublin, D02 FK...Phone Number
+353 16334028Website
www.seroba-lifesciences.comRevenue
<$5 MillionIndustry
About Seroba Life Sciences Management
Is Seroba Life Sciences Management your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Seroba Life Sciences Management is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Seroba Life Sciences Management has recently received funding, and reach out quickly before it becomes old news!
Seroba Life Sciences Management, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Seroba Life Sciences Management recently announced quarterly report
Product Launch: Get notified when Seroba Life Sciences Management launches new products
Funding: Get notified immidiatlly once Seroba Life Sciences Management has new funding data
Congratulate Masked Content for being promoted to Masked Content at Seroba Life Sciences Management
Click to see if Seroba Life Sciences Management had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Seroba Life Sciences Management is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Seroba Life Sciences Management is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Seroba Life Sciences Management.
Seroba Life Sciences Management Tech Stack
A closer look at the technologies used by Seroba Life Sciences Management
Most Recent Scoops
Seroba Life Sciences Management News & Media
Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment
GALWAY, Ireland--(BUSINESS WIRE)--Neurovascular medical device company Perfuze raise €22.5m ($25m) Series A for new stroke treatmentCoave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
- Coave Therapeutics is the new name for Horama and reflects its new emphasis on AAV-Ligand Conjugate based vectors for CNS diseases alongside Ocular diseases - Funding led by Seroba Life Sciences and supported by Théa Open Innovation, eureKARE and existing shareholders PARIS, July 21,...Quanta Raises $245M In Series D Funding
Quanta Dialysis Technologies Ltd, an Alcester, England, and Beverly, MA-based medical technology company focusing dialysis care, raised $245m in Series D funding. The round was led by Glenview Capital and co-led by Novo Holdings, with participation from BlackRock, Eldridge, Sands Capital, Millennium Management, Monashee Investment Management LLC., Puhua Capital, Segulah Medical and Ancora, alongside Orlando […] The post Quanta Raises $245M In Series D Funding appeared first on FinSMEs.Shorla Pharma Closes $8.3M Series A Funding Round
Shorla Pharma Limited ('Shorla'), an Irish specialty pharmaceutical company, has today announced the completion of a Series A investment of $8.3 million. The financing was led by Seroba Life Sciences ('Seroba'), a European Venture Capital firm headquartered in Dublin, Ireland with additional investment from Irish and Canadian based family offices and participation from Enterprise Ireland.
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seroba Life Sciences Management
Seroba is a European life sciences venture capital firm, focused on investing in winning innovations in biotech and medtech. The team has deep investment and industry experience enabling us to help and support entrepreneurs realise their ambitions whilst creating value for investors. The firm has three funds under management and has built a portfol... Read More